se of Red Propolis from Alagoas for the treatment of injuries resulting from the treatment of oral cancer

Not Applicable

Recruiting

• Conditions: Mouth Neoplasms; C04.588.443

• Registration Number: RBR-10d3bt7g
• Lead Sponsor: Centro de Estudos Superiores de Maceió-CESMAC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-03
• Last Update Posted: 26 July 2023
• Study Completion: 2024-04-30

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Participants of both sexes; aged between 18 and 64 years; under antineoplastic treatment; with oral and oropharyngeal cancer that fits into at least one of the following International Disease Classifications - ICD C01, C02, C03, C04, C05, C06, C07, C08, C09 or C10

Exclusion Criteria

Research participants with intellectual or non-collaborative difficulties that may hinder the use of the propolis-based orodispersible film and participation in complementary exams; pregnant research participants, as there is not enough evidence on the safe use of low power laser and red propolis from Alagoas for this group; research participants who present with severe immunosuppression and inability to leave the hospital environment because they are not responsive to the therapies used in the study; participants who refuse to sign the TCLE and participants who are allergic to film components (propolis and Crustaceans)]

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected to find an improvement in pain, within a period of 7 days, verified through the visual analogue pain scale (VAS), from the verification of a variation of at least 30% in the measurements from the beginning of the symptoms to the end of the period of treatment.;It is expected to find an improvement in healing, in a period of 7 days, verified by the healing of the lesions accompanied by clinical images photographed using a Z Flip 3 cell phone, based on the verification of a variation of at least 50% in the measurements since the onset of symptoms until the end of the treatment period.

Secondary Outcome Measures

Name	Time	Method
secondary outcomes are not expected